PARP1 and central nervous system cancer: Therefore, it is hypothesized that a PARP1-specific aptamer would exhibit dual action, enhancing the DNA-damaging effects of radiation and modulating signaling cascades that underlie glioma aggressiveness and radiation-induced invasion [39,40].